742-P: Antidrug Antibodies Do Not Impact Pharmacokinetics, Efficacy, and Safety of Tirzepatide: Analysis of Data from 7 Phase 3 Studies - CALDERON, BORIS; MULLINS, GARRETT R.; HODSDON, MICHAEL; LI, GRACE; ANGLIN, GREG; URVA, SHWETA; SCHNECK, KAREN; BARDOS, JENNIFER N.; MARTINS, RICARDO F.; BROWN, KATELYN (Diabetes (New York, N.Y.), 2022)
Keywords: Amino acids; Antibodies; Antidiabetics; Clinical trials; Diabetes; Diabetes mellitus (non-insulin dependent); GIP protein; GLP-1 receptor agonists; Glucagon; Hypersensitivity; Immune response; Immunogenicity; Patients; Peptides; Pharmacokinetics; Safety; Japan